Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins

Li, KX; Huo, QJ; Dimmitt, NH; Qu, GF; Bao, JJ; Pandya, PH; Saadatzadeh, MR; Bijangi-Vishehsaraei, K; Kacena, MA; Pollok, KE; Lin, CC; Li, BY; Yokota, H; Mohan, S

Li, BY (通讯作者)，Harbin Med Univ, Sch Pharm, Dept Pharmacol, Harbin, Peoples R China.;Yokota, H (通讯作者)，Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.;Yokota, H (通讯作者)，Indiana Univ Sch Med, Indiana Univ, Simon Comprehens Canc Ctr, Indianapolis, IN 46202 USA.;Yokota, H (通讯作者)，Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA.

ELIFE, 2023; 12 ():

Abstract

Osteosarcoma (OS) is the common primary bone cancer that affects mostly children and young adults. To augment the standard-of-care chemotherapy, we ex......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索